Research output per year
Research output per year
Personal profile
Biography
John Radford is Professor of Medical Oncology at the University of Manchester and Director of Research at the Christie NHS Foundation Trust, both partners in the Manchester Cancer Research Centre (MCRC). His research interests are focused on developing and testing new ways of treating lymphoma and monitoring the effectiveness of these using novel biomarkers. He is also interested in studying the late effects of chemotherapy on fertility, heart function and the risk of second cancers.
John chairs the Manchester Lymphoma Group, is immediate past chair of the UK National Cancer Research Institute (NCRI) Lymphoma Clinical Studies Group and is chief investigator for several national/international trials. He has advised the Parliamentary Ombudsman, NICE and the National Horizon Scanning Centre and is a member of the Editorial Board of the Journal of Clinical Oncology. He became honorary President of Lymphoma Action in September 2019.
Qualifications
- - MB ChB, MD, FRCP, FMedSci
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
FRCP
Award Date: 1 Jun 1997
Doctor of Medicine, Aspects of the Biological Effects of MVPP Chemotherapy for Hodgkin's Disease, The University of Sheffield
Award Date: 1 Oct 1992
Bachelor of Medicine, MB ChB, The University of Sheffield
Award Date: 30 Jun 1978
External positions
Chairman of NCRI Lymphoma Clinical Studies Group, National Cancer Research Institute (NCRI)
Director of Research: The Christie Hospital NHS Foundation Trust
Research Beacons, Institutes and Platforms
- Cancer
- Digital Futures
- Manchester Cancer Research Centre
Keywords
- Cancer
- Lymphoma
- Immunology
Fingerprint
Dive into the research topics where John Radford is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphoma
Palomba, M. L., Ghione, P., Patel, A. R., Nahas, M., Beygi, S., Hatswell, A. J., Kanters, S., Limbrick-Oldfield, E. H., Wade, S. W., Ray, M. D., Owen, J., Neelapu, S. S., Gribben, J., Radford, J. & Bobillo, S., Feb 2023, In: Expert Review of Anticancer Therapy. 23, 2, p. 199-206 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Interobserver variability in interim PET assessment in Hodgkin lymphoma-reasons and solutions
Georgi, T. W., Kurch, L., Hasenclever, D., Warbey, V. S., Pike, L., Radford, J., Sabri, O., Kluge, R. & Barrington, S. F., 28 Mar 2023, (E-pub ahead of print) In: PLoS ONE. 18, 3, e0283694.Research output: Contribution to journal › Article › peer-review
Open Access -
Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659)
Gordon, L. I., Karmali, R., Kaplan, J. B., Popat, R., Burris, H. A., Ferrari, S., Madan, S., Patel, M. R., Gritti, G., El-Sharkawi, D., Chau, F. I., Radford, J., de Oteyza, J. P., Zinzani, P. L., Iyer, S. P., Townsend, W., Miao, H., Proscurshim, I., Wang, S., Katyayan, S., & 6 others, 26 Jan 2023, In: Oncotarget. 14, p. 57-70 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
The iR2 regimen (ibrutinib plus lenalidomide and rituximab) for relapsed/refractory DLBCL: a multicentre, non-randomised, open-label phase 2 study
Ramchandren, R., Johnson, P., Ghosh, N., Ruan, J., Ardeshna, K. M., Johnson, R., Verhoef, G., Cunningham, D., de Vos, S., Kassam, S., Fayad, L., Radford, J., Bailly, S., Offner, F., Morgan, D., Munoz, J., Ping, J., Szafer-Glusman, E., Eckert, K., Neuenburg, J. K., & 1 others, 1 Feb 2023, In: EClinicalMedicine. 56, p. 101779Research output: Contribution to journal › Article › peer-review
Open Access -
The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network
Hapgood, G., Civallero, M., Stepanishyna, Y., Vose, J. M., Cabrera, M. E., Advani, R. H., Pileri, S. A., Manni, M., Horwitz, S. M., Foss, F. M., Hitz, F., Radford, J., Dlouhy, I., Chiattone, C. S., Kim, W-S., Skrypets, T., Nagler, A., Trotman, J., Luminari, S. & Federico, M., 10 May 2023, (E-pub ahead of print) In: Blood Advances.Research output: Contribution to journal › Article › peer-review
-
NIHR Manchester Biomedical Research Centre
Bruce, I., Lord, G., Lennon, R., Black, G., Wedge, D., Morris, A., Hussell, T., Sharrocks, A., Stivaros, S., Buch, M., Gough, J., Kostarelos, K., Thistlethwaite, F., Kadler, K., Barton, A., Hyrich, K., Mcbeth, J., O'Neill, T., Vestbo, J., Simpson, A., Singh, S., Smith, J., Felton, T., Murray, C., Griffiths, C., Cullum, N., Rhodes, L., Warren, R., Paus, R., Dumville, J., Viros Usandizaga, A., Keavney, B., Tomaszewski, M., Allan, S., Body, R., Cartwright, E., Heagerty, A., Kalra, P., Miller, C., Rutter, M., Smith, C., Trafford, A., Evans, D., Crosbie, E., Crosbie, P., Harvie, M., Howell, S., Renehan, A., Dive, C., Blackhall, F., Landers, D., Krebs, M., Cook, N., Clarke, R., Taylor, S., Jorgensen, C., Lorigan, P., Jayson, G., Valle, J., Mccabe, M., Armstrong, A., Freitas, A., Illidge, T., Choudhury, A., Hoskin, P., West, C., Van Herk, M., Faivre-Finn, C., Bristow, R., Kirkby, K., Birtle, A., Mackay, R., Radford, J., Linton, K., Higham, C., Munro, K., Plack, C., Arden Armitage, C., Bruce, I., Moore, D., Saunders, G., Stone, M., Haddock, G., Lewis, S., Elliott, R., Green, J., Lovell, K., Morrison, A., Shaw, J., Bucci, S., Ainsworth, J., Webb, R., Newman, W., Banka, S., Clayton-Smith, J., Payne, K., Moldovan, R., Wynn, R. & Jones, S.
1/12/22 → 30/11/27
Project: Research
-
NIHR Biomedical Research Centre: Cancer Precision Medicine Theme.
Dive, C., Baena Chaparro, E., Blackhall, F., Bruce, I., Bundred, N., Carter, L., Clarke, R., Cook, N., Crosbie, P., Evans, D., Harris, J., Hawkins, R., Hussell, T., Illidge, T., Jayson, G., Jorgensen, C., Kirwan, C., Kostarelos, K., Krebs, M., Lorigan, P., Marais, R., Marshall, K., Metcalf, R., Payne, K., Radford, J., Somervaille, T., Springer, C., Taylor, S., Thistlethwaite, F., Viros Usandizaga, A. & Zelenay, S.
1/04/17 → 31/03/19
Project: Research
-
Manchester Molecular Pathology Innovation Centre (MMPathIC): Bridging the Gap Between Biomarker Discovery and Health and Wealth.
Freemont, A., Ananiadou, S., Barton, A., Black, G., Bruce, I., Buchan, I., Byers, R., Dive, C., Goodacre, R., Griffiths, C., Hoyland, J., Payne, K., Radford, J. & Whetton, A.
1/10/15 → 31/03/21
Project: Research
Impacts
-
Access to more effective therapies in Non-Hodgkin Lymphoma
Timothy Illidge (Participant), John Radford (Participant) & Jamie Honeychurch (Participant)
Impact: Health and wellbeing, Economic
-
Improving survival and reducing treatment damage in Hodgkin lymphoma.
John Radford (Participant) & Timothy Illidge (Participant)
Impact: Health and wellbeing
-
Improving survival and reducing treatment damage in Hodgkin lymphoma (from JAN 2021)
John Radford (Participant) & Timothy Illidge (Participant)
Impact: Health and wellbeing